Nigeria Government Making Moves to Fund Ivermectin Research Targeting COVID-19: IVERCOVID Program

Nigeria Government Making Moves to Fund Ivermectin Research Targeting COVID-19 IVERCOVID Program

The Nigerian federal government commissioned a team of researchers to investigate the efficacy of Ivermectin as a potential treatment for COVID-19. Known as “IVERCOVID,” this group just may impact the world’s approach to treating COVID-19, at least in the developing world. The world’s sixth most populous nation (213 million people), Nigeria, like many nations in Sub-Saharan African, was spared the worst of the pandemic to date as compared to places like Europe, the United States or even South Africa. With about 104,000 recorded cases of SARS-CoV-2 infections, about 1,382 people have died due to the pandemic thus far. If COVID-19’s impact in the nation were to intensify during this second wave, the country’s ability to organize a defense would benefit from a low cost, easily accessible, early stage treatment and potential prophylactic—such as ivermectin, if it turns out to be effective. Standard measures to combat the virus, such as social distancing, face daunting challenges in a nation like Nigeria; the Academic Staff Union of Universities (ASUU), for example, recently shared the difficulties involving social distancing in crowded classes and hostels. Some cities such as Lago wit...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee